Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-FR | Version v5-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2017-06-14 | 2017-06-14 |
| Drug Identification Number | 01997653 | 01997653 |
| Brand name | DANTRIUM CAPSULES | DANTRIUM CAPSULES |
| Common or Proper name | DANTROLENE SODIUM CAPSULES | DANTROLENE SODIUM CAPSULES |
| Company Name | PAR PHARMACEUTICAL COMPANIES | PAR PHARMACEUTICAL COMPANIES |
| Ingredients | DANTROLENE SODIUM | DANTROLENE SODIUM |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | CAPSULE | CAPSULE |
| Route of administration | ORAL | ORAL |
| Packaging size | BOTTLE (100 COUNT) | BOTTLE (100 COUNT) |
| ATC code | M03CA | M03CA |
| ATC description | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2017-06-13 | 2017-06-13 |
| Remaining supply date | 2017-06-13 | 2017-06-13 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |